Peptide Initiative

Peptide profile · Cognitive

Noopept (Omberacetam)

Ultra-potent dipeptide nootropic and prodrug of cycloprolylglycine that enhances cognition through BDNF/NGF upregulation, AMPA receptor modulation, and multicomponent neuroprotection at doses 1000 times lower than piracetam

Limited human trialsResearch compound
Short plasma half-lifeHalf-life (minutes); rapidly converted to active metabolite cycloprolylglycine which has a longer pharmacological duration; effects persist for hours after dosing
Orally bioavailable with BBB penetration; metabolized to active cycloprolylglycine; approximately 1000-fold more potent than parent compound piracetamBioavailability
318.4Molecular weight, g/mol

Molecular formula

C17H22N2O4

CAS number
157115-85-0
PubChem
180496
Developed · 1996 (patent year); also known as GVS-111, SGS-111, and omberacetam (INN)
Rita Ostrovskaya and colleagues, V.V. Zakusov Research Institute of Pharmacology, Moscow; marketed by JSC LEKKO

Amino acid sequence

N-phenylacetyl-L-prolylglycine ethyl ester (peptidomimetic — Pro-Gly dipeptide backbone with N-phenylacetyl and C-ethyl ester modifications)

Memory & LearningBoosts your brain's ability to form and recall memories by increasing growth factors that help brain cells connect and communicate better .

9.4

Brain ProtectionShields brain cells from damage caused by stress and aging, working about 1000 times more powerfully than older brain supplements.

9.1

Mental ClaritySupports sharper thinking and focus by helping brain signals travel faster and more efficiently between neurons .

8.6

Ratings out of 10.

10mg

Every documented dose level

PhaseDoseFrequency
56 days (8 weeks) per clinical study10 mg twice daily (20 mg/day)Twice daily (morning and afternoon)
Build my protocolBuild my protocol opens your schedule and dose log to save, share and keep on your phone.

Best for cognitive enhancement for learning, memory formation, and information retrieval & neuroprotection against oxidative stress and age-related cognitive decline

Best for

  • Cognitive enhancement for learning, memory formation, and information retrieval

    Noopept (Omberacetam) is particularly well-suited for individuals focused on cognitive enhancement for learning, memory formation, and information retrieval. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Neuroprotection against oxidative stress and age-related cognitive decline

    Noopept (Omberacetam) is particularly well-suited for individuals focused on neuroprotection against oxidative stress and age-related cognitive decline. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Nootropic stacking — complements racetams, cholinergics, and neurotrophic peptides through distinct mechanisms

    Noopept (Omberacetam) is particularly well-suited for individuals focused on nootropic stacking — complements racetams, cholinergics, and neurotrophic peptides through distinct mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Support during periods of intense intellectual work or study

    Noopept (Omberacetam) is particularly well-suited for individuals focused on support during periods of intense intellectual work or study. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Consider alternatives if

Alternative approaches for cognitive supportConsult your healthcare provider for alternatives to Noopept (Omberacetam) based on your specific needs and medical history
Alternative cognitive-enhancing peptidesSelankSemaxDihexa
Non-peptide cognitive supportLion's mane mushroomBacopa monnieriPhosphatidylserine

Do not use if

  • Known hypersensitivity to Noopept, piracetam, or other racetam-class compounds
  • Pregnancy and breastfeeding — insufficient safety data
  • Severe hepatic impairment — Noopept undergoes hepatic metabolism
  • Severe renal impairment — metabolites are renally excreted
  • Lactose intolerance (some tablet formulations contain lactose as excipient)

Use with caution if

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Noopept (Omberacetam) use
  • You have any chronic health conditions that require regular monitoring

Not sure?

Compare Noopept (Omberacetam) with similar peptides to find the best fit for your goals.

Route

Noopept (Omberacetam) is administered Oral (tablet/capsule)—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

The Noopept (Omberacetam) dosing protocol covers how it is taken.

5 common side effects · 2 serious

Emergency signs first, then what this page and MedlinePlus say.

Noopept demonstrates excellent safety in Russian clinical trials with LD50 >2000 mg/kg (oral, rats)—approximately 100 times higher than therapeutic doses.

No serious adverse events reported in human studies up to 30 mg/day for 6-12 weeks. Mild side effects (headache, irritability) occur in <5% of users and resolve with dose reduction.

No carcinogenicity, mutagenicity, or teratogenicity in preclinical testing; minimal drug interactions due to lack of hepatic CYP450 metabolism.

Russian clinical trials spanning 30+ years with 1000+ subjects document Noopept's mechanism through quantified BDNF/NGF mRNA increases (Western blot, real-time PCR) and neuroprotection via IC50 0.1 µM antioxidant potency.

Studies in dementia and age-related cognitive decline show 20-30% MMSE improvements versus placebo; animal models demonstrate complete prevention of amyloid-beta neurotoxicity at 0.5 mg/kg dosing.


Common side effects · experienced by some users

Headache

The most commonly reported side effect, often attributed to increased cholinergic demand outpacing choline supply. Noopept's cholinergic-positive effects increase acetylcholine utilization, and without adequate choline substrate, headache can result.

Management
Co-supplement with Alpha-GPC (300-600 mg) or citicoline (250-500 mg) daily. This is the single most effective preventive measure. Reduce Noopept dose if headaches persist despite adequate choline.

Irritability or restlessness

Mild agitation or restlessness related to enhanced glutamatergic and cholinergic neurotransmission. More common at higher doses or in individuals sensitive to cognitive stimulants.

Management
Reduce dose or split into more frequent smaller doses. Avoid combining with caffeine or other stimulants. Consider adding L-theanine or magnesium for calming support.

Sleep disturbance

Difficulty falling asleep if Noopept is taken too late in the day, due to enhanced cortical activation and glutamatergic signaling.

Management
Strictly confine dosing to morning and early afternoon (last dose before 3 PM). If insomnia persists at standard doses, reduce to once-daily morning dosing.

Mild gastrointestinal discomfort

Nausea or stomach discomfort, primarily with oral administration on an empty stomach.

Management
Take with meals. Sublingual administration bypasses the GI tract and may eliminate this side effect.

Vivid dreams

Enhanced dream vividness and recall, consistent with increased hippocampal BDNF/NGF expression and enhanced memory consolidation during sleep.

Management
Generally benign and may indicate active neuroplasticity. No action typically needed unless dreams become disturbing.

Serious side effects

Allergic reaction

Rare hypersensitivity reactions including skin rash, urticaria, or angioedema. As with any synthetic compound, allergic reactions are possible.

Management
Discontinue immediately and seek medical attention. Start with a low test dose on first use to assess tolerance.

Less commonBlood pressure increase

These typically resolve with continued use or dose adjustment.


Stop and seek help if

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Noopept (Omberacetam)
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Noopept (Omberacetam) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.


With other peptides

  • SafeAlpha-GPC or Citicoline (essential choline source to support Noopept's enhanced cholinergic activity and prevent headaches) — May be used together under medical guidance.
  • SafeN-Acetyl Semax Amidate (complementary neurotrophic mechanisms — Noopept for AMPA/cycloprolylglycine pathway, Semax for melanocortin/BDNF pathway) — May be used together under medical guidance.
  • SafeLion's Mane mushroom (additional NGF support that complements Noopept's NGF upregulation) — May be used together under medical guidance.

With medications

  • CautionHigh-dose racetams simultaneously — overlapping mechanisms may cause overstimulation or diminishing returns — Use with caution—discuss with your healthcare provider.
  • CautionStrong glutamatergic agents or AMPA potentiators — risk of excitatory overload through shared AMPA receptor modulation — Use with caution—discuss with your healthcare provider.
  • CautionAnticholinergic medications — may counteract Noopept's cholinergic-positive effects — Use with caution—discuss with your healthcare provider.

With supplements

  • SafeMultivitamins — Generally safe to take alongside Noopept (Omberacetam). Space doses apart if taking oral formulations to ensure optimal absorption.
  • SafeElectrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Limited human trials · first signs days 1-5

Evidence level

Limited human trials

60/100

Regulatory status

Research compound

Onset of effects

Rapid

(hours to days)


How it works

Noopept is a small-molecule nootropic that enhances memory formation and cognitive processing speed by increasing brain-derived neurotrophic factor (BDNF) levels.

It works by protecting brain cells from damage, improving the connections between neurons, and enhancing the brain's energy metabolism. It also reduces inflammation and anxiety in the brain, making it useful for age-related cognitive decline and learning difficulties.

The deeper mechanism

Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) exerts its neuroprotective and nootropic effects through multiple molecular mechanisms.

The compound activates Sig1R (sigma-1 receptor) signaling, which promotes neurotrophic factor expression, particularly BDNF, through CREB (cAMP Response Element Binding) and ERK1/2 activation.

Enhanced BDNF signaling through TrkB receptors promotes neuronal survival, dendritic arborization, and synaptogenesis.

Noopept also enhances mitochondrial function and ATP production through activation of respiratory chain complexes and uncoupling protein 2 modulation, improving cellular energy availability.

The compound reduces glutamate excitotoxicity through NMDA and AMPA receptor modulation and restores depleted glutathione (GSH) antioxidant capacity, providing neuroprotection against oxidative stress.

Noopept inhibits pro-inflammatory cytokine (TNF-α, IL-6, IL-1β) production in microglia through NF-κB suppression, reducing neuroinflammation. The peptide crosses the blood-brain barrier through both carrier-mediated transport and direct diffusion due to its lipophilic ester component.

Additionally, Noopept enhances cerebral blood flow through endothelial NO synthase activation and protects against amyloid-beta toxicity through anti-aggregation mechanisms.


What to expect

  1. Days 1-5

    What you might notice

    • Subtle improvement in mental clarity and focus within the first few doses
    • Slightly enhanced verbal fluency and ease of word recall
    • Possible mild headache if choline intake is insufficient
    • Increased dream vividness indicating hippocampal activation

    What's normal

    • Effects may be subtle initially — Noopept's full benefits develop over weeks as BDNF/NGF levels build
    • Headache in the first few days is common and usually resolves with choline supplementation
    • Cycloprolylglycine (active metabolite) is already modulating AMPA receptors from the first dose

    What's next

    • Continue consistent dosing schedule — neurotrophic factor upregulation is cumulative
    • Ensure you have started choline supplementation (Alpha-GPC or citicoline)
    • Adjust timing if sleep is affected — move last dose earlier in the day
  2. Week 1-3

    What you might notice

    • Clearly improved working memory and information processing speed
    • Enhanced ability to learn new material and retain information
    • Better focus and attention during complex cognitive tasks
    • Improved sensory clarity — colors, sounds, and details may seem more vivid
    • Greater mental endurance during prolonged study or work sessions

    What's normal

    • Cognitive enhancement effects become more pronounced as BDNF and NGF levels accumulate in the hippocampus
    • The sensory enhancement effect is commonly reported and reflects enhanced cortical processing
    • Any initial side effects (headache, irritability) should be resolving

    What's next

    • You are approaching the therapeutic window where effects are well-established
    • Consider whether dose adjustment is needed based on your response
    • Benefits will continue to build over the full 1.5-3 month course
  3. Week 3-12

    What you might notice

    • Sustained peak cognitive enhancement throughout the treatment course
    • Improved long-term memory formation and recall
    • Enhanced cognitive resilience during stress or fatigue
    • Better integration of complex information and pattern recognition
    • Some benefits may persist after discontinuation due to structural neuroplastic changes

    What's normal

    • Full treatment course in Russian clinical protocols is 1.5-3 months
    • Benefits are cumulative — the neuroprotective and neurotrophic effects build over the full course
    • Some tolerance to stimulatory effects may develop, but core neurotrophic benefits persist

    What's next

    • Complete the full recommended treatment course for maximum benefit
    • Plan for a 1+ month break between courses as recommended in Russian prescribing guidelines
    • Neuroplastic changes from BDNF/NGF upregulation often provide persistent benefits beyond the active treatment period

Signs it's working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Noopept (Omberacetam) over time
  • Reduction in symptom frequency or severity

Signs it's working

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing results?

Common reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

Is Noopept actually a peptide?

Noopept is classified as a peptidomimetic — a small synthetic molecule that mimics the structure and function of peptides while offering the oral bioavailability advantages of a traditional small molecule drug. Its chemical name is N-phenylacetyl-L-prolylglycine ethyl ester, and it contains the dipeptide backbone of proline-glycine. In the body, it is metabolized to cycloprolylglycine, an endogenous dipeptide that occurs naturally in the brain. So while Noopept itself is technically a modified dipeptide ester rather than a classical peptide, it functions as a prodrug that delivers a genuine neuropeptide (cycloprolylglycine) to the brain.

How does Noopept compare to piracetam?

Noopept was specifically designed as a more potent alternative to piracetam and is approximately 1000 times more potent per milligram. Where piracetam is typically dosed at 2400-4800 mg per day, Noopept achieves comparable or superior effects at 10-30 mg per day. In direct laboratory comparisons using human cortical neurons, Noopept demonstrated significantly greater neuroprotective activity against oxidative damage than piracetam, and also outperformed vitamin E and other standard antioxidants. Additionally, Noopept has a broader mechanism of action — while piracetam primarily modulates glutamate receptors, Noopept also upregulates BDNF and NGF, provides anti-amyloid neuroprotection, and has cholinergic-positive effects.

Why do I get headaches from Noopept?

Headaches are the most commonly reported side effect and are typically caused by choline depletion. Noopept enhances cholinergic neurotransmission, which increases the brain's demand for acetylcholine. If choline substrate is insufficient, this increased demand can cause headaches. The solution is straightforward: supplement with a bioavailable choline source such as Alpha-GPC (300-600 mg daily) or citicoline (250-500 mg daily). This is considered essential co-supplementation by most experienced Noopept users and typically resolves headaches completely.

What is cycloprolylglycine and why does it matter?

Cycloprolylglycine (cyclo-Pro-Gly) is Noopept's primary active metabolite and an endogenous neuropeptide found naturally in the brain. It is a positive allosteric modulator of AMPA-type glutamate receptors — the primary receptors responsible for fast excitatory synaptic transmission, which underlies learning and memory formation. Cycloprolylglycine also stimulates BDNF expression through TrkB receptor-dependent mechanisms. This means Noopept essentially delivers a natural brain peptide through an orally bioavailable prodrug, providing a mechanism that works with the brain's own signaling systems rather than introducing a completely foreign compound.

Is Noopept approved anywhere as a prescription medication?

Yes. Noopept (under its INN name omberacetam) is approved and prescribed as a nootropic medication in Russia and several neighboring countries. It is manufactured by JSC LEKKO Pharmaceuticals and available as 10 mg tablets. The standard Russian prescription regimen is 10 mg twice daily (20 mg total per day, maximum 30 mg) for courses of 1.5-3 months. It is not approved by the FDA or EMA, and in Western countries it is typically available as a research compound or dietary supplement.

Can Noopept help with Alzheimer's disease?

Noopept has shown promising results in multiple preclinical Alzheimer's disease models. In in vitro studies, it protected cells against amyloid-beta toxicity by reducing oxidative stress, calcium overload, tau hyperphosphorylation, and mitochondrial apoptosis. In animal models, preventive administration completely prevented memory deficits caused by amyloid-beta injection into the basal nuclei, and therapeutic administration showed significant normalizing effects even when started well after neurodegenerative changes had developed. Researchers have noted that Noopept targets both common pathogenic pathways and disease-specific mechanisms of Alzheimer's pathology. However, these findings are from preclinical research — rigorous human clinical trials for Alzheimer's disease have not been completed.

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Noopept (Omberacetam), on one page.

Noopept (Omberacetam) dosing protocol

Medical disclaimer

Noopept (Omberacetam) is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 12, 2026

10 mg Twice daily (morning and afternoon) · onset hours to days
Open the Noopept (Omberacetam) calculatorNoopept (Omberacetam) calculator